XCUR Exicure Inc

Price (delayed)

$3.02

Market cap

$19.25M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.55

Enterprise value

$16.65M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 0

Exicure, Inc. is a clinical-stage biotechnology company developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on its proprietary Spherical Nucleic Acid, or SNA technology. Exicure believes its proprietary ...

Highlights
The debt has plunged by 100% YoY
Exicure's EPS has plunged by 96% from the previous quarter but it has soared by 59% YoY
The net income has dropped by 98% since the previous quarter and by 67% year-on-year
XCUR's equity has dropped by 82% year-on-year and by 47% since the previous quarter

Key stats

What are the main financial stats of XCUR

XCUR stock price

How has the Exicure stock price performed over time
Intraday
-4.43%
1 week
1.68%
1 month
-7.08%
1 year
-70.25%
YTD
-44.28%
QTD
-29.02%

Financial performance

How have Exicure's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$5.52M
Net income
-$9.78M
Gross margin
N/A
Net margin
N/A
The net income has dropped by 98% since the previous quarter and by 67% year-on-year
XCUR's operating income has surged by 61% year-on-year but it is down by 30% since the previous quarter

Price vs fundamentals

How does XCUR's price correlate with its fundamentals

Growth

What is Exicure's growth rate over time

Valuation

What is Exicure stock price valuation
P/E
N/A
P/B
9.18
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Exicure's EPS has plunged by 96% from the previous quarter but it has soared by 59% YoY
XCUR's P/B is 118% above its 5-year quarterly average of 4.4 and 26% above its last 4 quarters average of 7.6
XCUR's equity has dropped by 82% year-on-year and by 47% since the previous quarter

Efficiency

How efficient is Exicure business performance
XCUR's ROE has shrunk by 182% QoQ and by 63% YoY
The ROA has plunged by 124% from the previous quarter and by 57% YoY

Dividends

What is XCUR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XCUR.

Financial health

How did Exicure financials performed over time
The company's total assets is 20% higher than its total liabilities
The quick ratio has plunged by 78% YoY and by 39% from the previous quarter
Exicure's current ratio has plunged by 73% YoY and by 34% from the previous quarter
The debt is 100% less than the equity
The debt has plunged by 100% YoY
XCUR's equity has dropped by 82% year-on-year and by 47% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.